InsiderTrades

Form 4 for VIR Vir Biotechnology, Inc.

Accepted 2022-08-26 00:00:00 ET · period of report 2022-08-24 · accession 0001062993-22-018811 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
MI 2022-08-26 2022-08-24+ VIR ARCH Venture Fund IX, L.P. 10% J - Other $0.00 -994.1K 6.71M -13% $0
M 2022-08-26 2022-08-24+ VIR ARCH Venture Fund IX, L.P. 10% J - Other $0.00 +29.1K 23.2K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-08-25 J D 282,219 $0.00 8,419,531 I — —
2 Common Common Stock 2022-08-25 J A 13,076 $0.00 220,666 D — — (F5) Shares held directly by Crandell.
3 Common Common Stock 2022-08-25 J A 1,475 $0.00 24,658 D — — (F6) Shares held directly by Bybee.
4 Common Common Stock 2022-08-25 J A 2,952 $0.00 49,346 I — — (F7) Shares held by a trust for the benefit of family members of Bybee.
5 Common Common Stock 2022-08-24 J D 282,219 $0.00 8,701,750 I See footnote — — (F3) These shares are directly held by ARCH Venture Fund IX Overage, L.P. ("ARCH Overage"). ARCH Venture Partners IX Overage, L.P. ("Overage GPLP"), as the sole general partner of ARCH Overage, may be deemed to beneficially own the shares held by ARCH Overage. GPLLC, as the sole general partner of Overage GPLP, may be deemed to beneficially own the shares held by ARCH Overage. As managing directors of GPLLC, each of the ARCH Managing Directors may be deemed to beneficially own the shares held by ARCH Overage. Each of Overage GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any.
6 Common Common Stock 2022-08-24 J A 13,076 $0.00 207,590 D See footnote — — (F5) Shares held directly by Crandell. (F7) Shares held by a trust for the benefit of family members of Bybee.
7 Common Common Stock 2022-08-24 J A 1,475 $0.00 23,183 D See footnote — — (F6) Shares held directly by Bybee. (F2) These shares are directly held by ARCH Venture Fund IX, L.P. ("ARCH IX"). ARCH Venture Partners IX, L.P. ("GPLP"), as the sole general partner of ARCH IX, may be deemed to beneficially own the shares held by ARCH IX. ARCH Venture Partners IX, LLC ("GPLLC"), as the sole general partner of GPLP, may be deemed to beneficially own the shares held by ARCH IX. As managing directors of GPLLC, each of Keith Crandell and Clinton Bybee (the "ARCH Managing Directors"), may be deemed to beneficially own the shares held by ARCH IX. Each of GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any.
8 Common Common Stock 2022-08-24 J A 2,952 $0.00 46,394 I See footnote — — (F7) Shares held by a trust for the benefit of family members of Bybee. (F3) These shares are directly held by ARCH Venture Fund IX Overage, L.P. ("ARCH Overage"). ARCH Venture Partners IX Overage, L.P. ("Overage GPLP"), as the sole general partner of ARCH Overage, may be deemed to beneficially own the shares held by ARCH Overage. GPLLC, as the sole general partner of Overage GPLP, may be deemed to beneficially own the shares held by ARCH Overage. As managing directors of GPLLC, each of the ARCH Managing Directors may be deemed to beneficially own the shares held by ARCH Overage. Each of Overage GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any.
9 Common Common Stock 2022-08-25 J D 217,781 $0.00 6,497,132 I See footnote — — (F7) Shares held by a trust for the benefit of family members of Bybee.
10 Common Common Stock 2022-08-24 J D 217,781 $0.00 6,714,913 I See footnote — — (F2) These shares are directly held by ARCH Venture Fund IX, L.P. ("ARCH IX"). ARCH Venture Partners IX, L.P. ("GPLP"), as the sole general partner of ARCH IX, may be deemed to beneficially own the shares held by ARCH IX. ARCH Venture Partners IX, LLC ("GPLLC"), as the sole general partner of GPLP, may be deemed to beneficially own the shares held by ARCH IX. As managing directors of GPLLC, each of Keith Crandell and Clinton Bybee (the "ARCH Managing Directors"), may be deemed to beneficially own the shares held by ARCH IX. Each of GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any.